JP2005507891A5 - - Google Patents

Download PDF

Info

Publication number
JP2005507891A5
JP2005507891A5 JP2003530312A JP2003530312A JP2005507891A5 JP 2005507891 A5 JP2005507891 A5 JP 2005507891A5 JP 2003530312 A JP2003530312 A JP 2003530312A JP 2003530312 A JP2003530312 A JP 2003530312A JP 2005507891 A5 JP2005507891 A5 JP 2005507891A5
Authority
JP
Japan
Prior art keywords
chito
oligomer
range
treatment
chain length
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003530312A
Other languages
English (en)
Japanese (ja)
Other versions
JP4613008B2 (ja
JP2005507891A (ja
Filing date
Publication date
Priority claimed from IS6085A external-priority patent/IS6085A/is
Application filed filed Critical
Publication of JP2005507891A publication Critical patent/JP2005507891A/ja
Publication of JP2005507891A5 publication Critical patent/JP2005507891A5/ja
Application granted granted Critical
Publication of JP4613008B2 publication Critical patent/JP4613008B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003530312A 2001-09-26 2002-09-26 キト−オリゴマーを含む医薬組成物 Expired - Lifetime JP4613008B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
PCT/IS2002/000016 WO2003026677A1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers

Publications (3)

Publication Number Publication Date
JP2005507891A JP2005507891A (ja) 2005-03-24
JP2005507891A5 true JP2005507891A5 (enExample) 2006-01-12
JP4613008B2 JP4613008B2 (ja) 2011-01-12

Family

ID=36700489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530312A Expired - Lifetime JP4613008B2 (ja) 2001-09-26 2002-09-26 キト−オリゴマーを含む医薬組成物

Country Status (13)

Country Link
US (2) US7985741B2 (enExample)
EP (1) EP1435976B1 (enExample)
JP (1) JP4613008B2 (enExample)
KR (1) KR20040062548A (enExample)
AT (1) ATE359797T1 (enExample)
CA (1) CA2507926C (enExample)
DE (1) DE60219653T2 (enExample)
DK (1) DK1435976T3 (enExample)
ES (1) ES2284935T3 (enExample)
IS (2) IS6085A (enExample)
PT (1) PT1435976E (enExample)
SI (1) SI1435976T1 (enExample)
WO (1) WO2003026677A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070500A1 (en) * 2001-12-13 2005-03-31 Boucher L Isabelle Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
US20070082851A1 (en) * 2003-11-24 2007-04-12 Optimer Pharmaceuticals Inc. Treatment of a condition in a mammal with administration of Compounds and Methods of Use
CA2551613A1 (en) * 2004-05-21 2005-12-01 Tottori University A composition comprising n-acetyl-d-glucosamine for treatment of wound
MX336736B (es) * 2005-06-14 2016-01-29 Genis Hf Composiciones de derivados de quitina parcialmente desacetilados.
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001282A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
EP2318014B1 (en) * 2008-07-18 2016-09-14 Genís hf. New composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
US9186377B2 (en) 2011-06-03 2015-11-17 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
EP3058826A1 (en) 2011-09-08 2016-08-24 Novozymes BioAG A/S Seed treatment methods and compositions
PL2748123T3 (pl) 2011-09-14 2024-05-13 Novozymes Bioag A/S Zastosowanie lipochito-oligosacharydów i/lub chito-oligosacharydów w kombinacji z mikroorganizmami solubilizującymi fosforany do poprawy wzrostu roślin
AU2012312006B2 (en) * 2011-09-23 2015-10-29 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing corn growth
CA2849898C (en) 2011-09-23 2020-10-27 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing plant growth
US9474828B2 (en) 2012-04-23 2016-10-25 Genis Hf. Self-hardening bioactive cement compositions with partially deacetylated chitin as bone graft substitutes
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
EP4511042A4 (en) * 2022-04-21 2026-04-22 Therapeutikos Inc METHODS OF TREATING INFLAMMATION

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
DE69733089T2 (de) * 1996-12-13 2005-09-29 Lescarden Inc. Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 2−アセチルアミノ−4−O−(2−アミノ−2−デオキシ−β−D −グルコピラノシル)−2−デオキシ−D −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
MX336736B (es) * 2005-06-14 2016-01-29 Genis Hf Composiciones de derivados de quitina parcialmente desacetilados.

Similar Documents

Publication Publication Date Title
CA2507926A1 (en) Pharmaceutical composition comprising chito-oligomers
JP2012506904A5 (enExample)
JP2006502129A5 (enExample)
JP2003522796A5 (enExample)
ES2259813T3 (es) Utilizacion del hialuronato de zinc contra la ulcera peptica.
JP2006501133A5 (enExample)
FI3223827T3 (fi) Ravintokuitukoostumus
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
JP2009501801A5 (enExample)
US6492350B2 (en) Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
JP2006516988A (ja) 持続した薬物放出またはムコ粘着のための活性剤およびキトサンを含む製薬組成物
MX2009000459A (es) Suspensiones farmaceuticas que comprenden fenilefrina y metodo de preparacion.
US20050009782A1 (en) Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
KR20110017819A (ko) 소화성 궤양과 십이지장 궤양 치료 및 예방을 위한 히알루론산 혼합물
JP2009543804A5 (enExample)
EP2040716B1 (en) Cellulose sulfate for the treatment of rhinovirus infection
AU2015261841B2 (en) Aqueous gel composition and its use
JP2012526099A5 (enExample)
CN101278933A (zh) 一种含有二甲啡烷的药物组合物及其制备方法
JP2010518075A5 (enExample)
CN101068530A (zh) 无染料药物悬浮液和相关方法
RU2004118493A (ru) Фармацевтическая суспензия для перорального применения
CN100460413C (zh) 羧酸类非甾体抗炎药与氨基葡萄糖或其盐合成的化合物及其合成方法和应用
CN214513656U (zh) 一种生物制药厂胶囊生产废气净化装置
CN102349883A (zh) 对乙酰氨基酚口腔速溶膜及其制备方法